DRAP

A new federal body will take over medicine pricing from DRAP, aligning with ongoing health sector reforms.

Federal cabinet’s move compelled by ‘rising rates of raw material in global market’

Skin treatments can only be performed by qualified professionals but there does not seem to be any check and balance

Drugs authority seizes toxic propylene glycol, linked to child deaths; recall issued, investigation underway

Say policies of regulatory body are not public friendly

Initiates regular enquiry into assets of Sheikh Akhtar Hussain

Sheikh Hussain is accused of holding fake PhD degree

Proposal to increase prices of 262 medicines prompts call for review of drug pricing methodology

Organization says DRAP found other products were also contaminated and issued a recall in Nov

Executive director says grey market has become bigger than white market

CEO urges govt to collaborate with industry stakeholders to drive innovation

70 substandard drugs unearthed in K-P; Punjab’s vision loss crisis spurs investigation

Regulator orders withdrawal of substandard batch of Comycetin eye drops from market

DRAP panel to liaise with pharmaceutical manufacturers, importers

Authority seeks opinion of the pharmaceutical companies concerned within 15 days.

The probe recommended that the promoted officers be reverted to their previous pay scales

CEO says authority working to steer ease of doing business to support companies

Gives edu dept 3 days to implement judicial orders on school principals regularisation

Rs22,500 set as fee for renewal of drug manufacturing licences

The action was taken in order to end the hegemony of different brands

Gives last warning to interior secretary to appear before court in missing persons case

Earlier, the Chinese vaccine was being administered to people up to the age of 60 years

Authority will provide online NOC to applicants with the ease of home

It is the first coronavirus vaccine to get the DRAP's green light, says Dr Faisal Sultan

Prototype handed over to Innovation and Testing Centre for clinical trials

DRAP’s app ‘helpful in identifying ADRs cases’

DRAP’s app ‘helpful in identifying ADRs cases’

Pirims will integrate registration, inspection, licensing, and monitoring of approved medicines

Prices of 68 local and 26 imported lifesaving drugs have been increased

DRAP tells pharmaceutical firms to recall hazardous batches

Will the govt risk letting pharma companies go rogue?

Pakistan’s continuing failure to embrace generic drugs is a significant part of the problem

 Drug Pricing Policy 2018 grants medicine companies right to increase prices annually by up to 10 %

Amends Drug Pricing Policy 2018 to allow 7% hike in prices of lifesavings drugs; 10% in other drugs

The next hearing of the case will be conducted after 10 days

Clinical trials will be conducted under DRAP supervision soon after approval of vaccines

DRAP issues guidelines for alternative medicines

Says such matters end up in courts for them to decide

Top drug regulator says chloroquine is in trial phase and not being used to treat Covid-19 patients

After health care workers, those working in chemist shops believed to be potential target of the deadly virus

It's mandatory to get approval from international health institutions before human trials, says Dr Tahir Shamsi

It stated that reports had emerged that some people were hoarding stocks of chloroquine phosphate

Almost 90% of the raw material used by the local pharmaceutical industry is imported from two neighbouring countries

Recent notification allowed surge in prices of 45,000 medicines

Takes a step forward to implement a paperless working environment

DRAP CEO says 15 pharmaceutical companies have moved courts instead of cutting down the prices of their medicines

SAPM on health says strict action will be taken against people selling overpriced medicines

Issues advisory to pharma firms manufacturing syrups using Levomethorphan

It will help authority improve its SOPs

MNAs concerned over poor standard of medical education